Add ADAL01

[edelarua]

Work from https://github.com/insightsengineering/tlg-catalog/pull/38 moved here due to repo restructuring since previous PR was created.

Closes #37

[edelarua]

Hi @qiliu1013,

After your refactor of ADAB in random.cdisc.data, the "treatment emergent status" data is no longer present in adab (see change here), and the ATACHAR variable is no longer present in adab (see change here). Consequently, the "Characterization Results", "Patient Treatment Emergent ADA Status", and "Patient Treatment Emergent NAb Status" columns can no longer be derived in this listing. How should we proceed?

I have commented out the broken parts of the code to create the listing for now, which generates ADAL01 without the four missing columns until this is fixed.

[qiliu1013]

Hi @qiliu1013,

After your refactor of ADAB in random.cdisc.data, the "treatment emergent status" data is no longer present in adab (see change here), and the ATACHAR variable is no longer present in adab (see change here). Consequently, the "Characterization Results", "Patient Treatment Emergent ADA Status", and "Patient Treatment Emergent NAb Status" columns can no longer be derived in this listing. How should we proceed?

I have commented out the broken parts of the code to create the listing for now, which generates ADAL01 without the four missing columns until this is fixed.

I will be out of office for the upcoming week but if you have any questions please feel free to reach out to anyone on the SME team!

Hi @edelarua, no need to show "Characterization Results" and "Patient Treatment Emergent NAb Status" in the ADAL01. A the new standard specs, there were move into PARAM now. We don't need to consider them. "Patient Treatment Emergent ADA Status" now was in PARAMCD = "ADASTAT1".

Did I answer all your questions?

Thanks, Qi

[edelarua]

Did I answer all your questions?

To confirm - "Patient Treatment Emergent ADA Status" also no longer need to be considered, correct? If so then yes you answered all my questions, and the template should be ready for review! Thanks Qi!!

[qiliu1013]

Did I answer all your questions?

To confirm - "Patient Treatment Emergent ADA Status" also no longer need to be considered, correct? If so then yes you answered all my questions, and the template should be ready for review! Thanks Qi!!

Sorry. Patient Treatment Emergent ADA Status is PARAMCD = "ADASTAT1". No need to consider "Patient Treatment Emergent NAb Status"

[github-actions[bot]]

Unit Tests Summary

340 tests   252 :white_check_mark:  59s :stopwatch: 135 suites   88 :zzz:   1 files      0 :x:

Results for commit c34f2825.

:recycle: This comment has been updated with latest results.

[qiliu1013]

Hi @edelarua, can you please share the output with me? Thanks!

[shajoezhu]

hi @qiliu1013 , can you review the output at https://github.com/insightsengineering/tlg-catalog/pull/116/files#diff-800dcce08155543ad547403b286591745b8c15d6d35a7b4fec7dc33a51da067c please

[edelarua]

@qiliu1013 see a screenshot of the TLG-C output here:

[shajoezhu]

blocking this for the moment. It seems we need some refactoring in the rcd data again.

[qiliu1013]

@shajoezhu and @edelarua, can you please let me know where to find the latest adal01 code? I didn't see it under 37_adal01 branch. Thanks!

[github-actions[bot]]

🎉 Thank you for your contribution! Before this PR can be accepted, we require that you all read and agree to our Contributor License Agreement.
You can digitally sign the CLA by posting a comment on this Pull Request in the format shown below. This agreement will apply to this PR as well as all future contributions on this repository.

---

I have read the CLA Document and I hereby sign the CLA

---

3 out of 4 committers have signed the CLA.
:white_check_mark: (edelarua)[https://github.com/edelarua]
:white_check_mark: (Melkiades)[https://github.com/Melkiades]
:white_check_mark: (shajoezhu)[https://github.com/shajoezhu]
:x: @Qi Liu
Qi Liu seems not to be a GitHub user. You need a GitHub account to be able to sign the CLA. If you have already a GitHub account, please add the email address used for this commit to your account.
_{You can retrigger this bot by commenting recheck in this Pull Request. Posted by the CLA Assistant Lite bot.}

[shajoezhu]

I have read the CLA Document and I hereby sign the CLA

[qiliu1013]

I have read the CLA Document and I hereby sign the CLA

[shajoezhu]

hi @edelarua , could you update the snapshot, once https://github.com/insightsengineering/random.cdisc.data/pull/317 is in please. Thanks!

[shajoezhu]

this is potentially blocked by https://github.com/insightsengineering/random.cdisc.data/issues/319

[edelarua]

Snapshot has been updated.

[shajoezhu]

blocked by #270

[github-actions[bot]]

Unit Test Performance Difference

Test suite performance difference

| Test Suite | $Status$ | Time on `main` | $±Time$ | $±Tests$ | $±Skipped$ | $±Failures$ | $±Errors$ | |:-----|:----:|:----:|:-----:|:-------:|:--------:|:------:|:------:| | graph-snaps | 💀 | $4.22$ | $-4.22$ | $-42$ | $-42$ | $0$ | $0$ | | graphs-efficacy-fstg01 | 👶 | | $+2.36$ | $+7$ | $+7$ | $0$ | $0$ | | graphs-efficacy-fstg02 | 👶 | | $+0.52$ | $+7$ | $+7$ | $0$ | $0$ | | graphs-efficacy-kmg01 | 👶 | | $+0.95$ | $+8$ | $+8$ | $0$ | $0$ | | graphs-efficacy-mmrmg01 | 👶 | | $+0.72$ | $+6$ | $+6$ | $0$ | $0$ | | graphs-efficacy-mmrmg02 | 👶 | | $+0.14$ | $+3$ | $+3$ | $0$ | $0$ | | graphs-other-brg01 | 👶 | | $+0.18$ | $+9$ | $+9$ | $0$ | $0$ | | graphs-other-bwg01 | 👶 | | $+0.65$ | $+9$ | $+9$ | $0$ | $0$ | | graphs-other-cig01 | 👶 | | $+0.22$ | $+5$ | $+4$ | $0$ | $0$ | | graphs-other-ippg01 | 👶 | | $+0.06$ | $+2$ | $+2$ | $0$ | $0$ | | graphs-other-ltg01 | 👶 | | $+0.16$ | $+7$ | $+7$ | $0$ | $0$ | | graphs-other-mng01 | 👶 | | $+0.43$ | $+7$ | $+7$ | $0$ | $0$ | | graphs-pharmacokinetic-pkcg01 | 👶 | | $+0.05$ | $+2$ | $+2$ | $0$ | $0$ | | graphs-pharmacokinetic-pkcg02 | 👶 | | $+0.05$ | $+2$ | $+2$ | $0$ | $0$ | | graphs-pharmacokinetic-pkcg03 | 👶 | | $+0.06$ | $+2$ | $+2$ | $0$ | $0$ | | graphs-pharmacokinetic-pkpg01 | 👶 | | $+0.06$ | $+2$ | $+2$ | $0$ | $0$ | | graphs-pharmacokinetic-pkpg02 | 👶 | | $+0.07$ | $+2$ | $+2$ | $0$ | $0$ | | graphs-pharmacokinetic-pkpg03 | 👶 | | $+0.04$ | $+1$ | $+1$ | $0$ | $0$ | | graphs-pharmacokinetic-pkpg04 | 👶 | | $+0.05$ | $+1$ | $+1$ | $0$ | $0$ | | graphs-pharmacokinetic-pkpg06 | 👶 | | $+0.07$ | $+4$ | $+4$ | $0$ | $0$ | | listings-ADA-adal02 | 👶 | | $+0.06$ | $+1$ | $0$ | $0$ | $0$ | | listings-ECG-egl01 | 👶 | | $+0.05$ | $+1$ | $0$ | $0$ | $0$ | | listings-adverse-events-ael01 | 👶 | | $+0.04$ | $+1$ | $0$ | $0$ | $0$ | | listings-adverse-events-ael01_nollt | 👶 | | $+0.03$ | $+1$ | $0$ | $0$ | $0$ | | listings-adverse-events-ael02 | 👶 | | $+0.06$ | $+1$ | $0$ | $0$ | $0$ | | listings-adverse-events-ael02_ed | 👶 | | $+0.07$ | $+1$ | $0$ | $0$ | $0$ | | listings-adverse-events-ael03 | 👶 | | $+0.05$ | $+1$ | $0$ | $0$ | $0$ | | listings-adverse-events-ael04 | 👶 | | $+0.04$ | $+1$ | $0$ | $0$ | $0$ | | listings-concomitant-medications-cml01 | 👶 | | $+0.06$ | $+1$ | $0$ | $0$ | $0$ | | listings-concomitant-medications-cml02a_gl | 👶 | | $+0.03$ | $+1$ | $0$ | $0$ | $0$ | | listings-concomitant-medications-cml02b_gl | 👶 | | $+0.04$ | $+1$ | $0$ | $0$ | $0$ | | listings-development-safety-update-report-dsur4 | 👶 | | $+0.04$ | $+1$ | $0$ | $0$ | $0$ | | listings-disposition-dsl01 | 👶 | | $+0.04$ | $+1$ | $0$ | $0$ | $0$ | | listings-disposition-dsl02 | 👶 | | $+0.04$ | $+1$ | $0$ | $0$ | $0$ | | listings-efficacy-oncl01 | 👶 | | $+0.05$ | $+1$ | $0$ | $0$ | $0$ | | listings-exposure-exl01 | 👶 | | $+0.05$ | $+1$ | $0$ | $0$ | $0$ | | listings-lab-results-lbl01 | 👶 | | $+0.05$ | $+1$ | $0$ | $0$ | $0$ | | listings-lab-results-lbl01_rls | 👶 | | $+0.05$ | $+1$ | $0$ | $0$ | $0$ | | listings-lab-results-lbl02a | 👶 | | $+0.05$ | $+1$ | $0$ | $0$ | $0$ | | listings-lab-results-lbl02a_rls | 👶 | | $+0.07$ | $+1$ | $0$ | $0$ | $0$ | | listings-lab-results-lbl02b | 👶 | | $+0.05$ | $+1$ | $0$ | $0$ | $0$ | | listings-medical-history-mhl01 | 👶 | | $+0.05$ | $+1$ | $0$ | $0$ | $0$ | | listings-pharmacokinetic-pkcl01 | 👶 | | $+0.04$ | $+1$ | $0$ | $0$ | $0$ | | listings-pharmacokinetic-pkcl02 | 👶 | | $+0.06$ | $+1$ | $0$ | $0$ | $0$ | | listings-pharmacokinetic-pkpl01 | 👶 | | $+0.04$ | $+1$ | $0$ | $0$ | $0$ | | listings-pharmacokinetic-pkpl02 | 👶 | | $+0.04$ | $+1$ | $0$ | $0$ | $0$ | | listings-pharmacokinetic-pkpl04 | 👶 | | $+0.05$ | $+1$ | $0$ | $0$ | $0$ | | listings-vital-signs-vsl01 | 👶 | | $+0.07$ | $+1$ | $0$ | $0$ | $0$ | | markdown-snaps | 💀 | $52.33$ | $-52.33$ | $-253$ | $-253$ | $0$ | $0$ | | tables-ADA-adat01 | 👶 | | $+0.21$ | $+1$ | $0$ | $0$ | $0$ | | tables-ADA-adat02 | 👶 | | $+0.08$ | $+1$ | $0$ | $0$ | $0$ | | tables-ADA-adat03 | 👶 | | $+0.33$ | $+1$ | $0$ | $0$ | $0$ | | tables-ADA-adat04a | 👶 | | $+0.14$ | $+1$ | $0$ | $0$ | $0$ | | tables-ADA-adat04b | 👶 | | $+0.12$ | $+1$ | $0$ | $0$ | $0$ | | tables-ECG-egt01 | 👶 | | $+0.54$ | $+1$ | $0$ | $0$ | $0$ | | tables-ECG-egt02 | 👶 | | $+0.17$ | $+2$ | $0$ | $0$ | $0$ | | tables-ECG-egt03 | 👶 | | $+1.40$ | $+2$ | $0$ | $0$ | $0$ | | tables-ECG-egt04 | 👶 | | $+0.17$ | $+1$ | $0$ | $0$ | $0$ | | tables-ECG-egt05_qtcat | 👶 | | $+0.47$ | $+1$ | $0$ | $0$ | $0$ | | tables-adverse-events-aet01 | 👶 | | $+0.47$ | $+4$ | $0$ | $0$ | $0$ | | tables-adverse-events-aet01_aesi | 👶 | | $+0.64$ | $+4$ | $0$ | $0$ | $0$ | | tables-adverse-events-aet02 | 👶 | | $+1.89$ | $+13$ | $0$ | $0$ | $0$ | | tables-adverse-events-aet02_smq | 👶 | | $+0.18$ | $+2$ | $0$ | $0$ | $0$ | | tables-adverse-events-aet03 | 👶 | | $+0.33$ | $+1$ | $0$ | $0$ | $0$ | | tables-adverse-events-aet04 | 👶 | | $+3.38$ | $+8$ | $0$ | $0$ | $0$ | | tables-adverse-events-aet04_pi | 👶 | | $+1.63$ | $+8$ | $0$ | $0$ | $0$ | | tables-adverse-events-aet05 | 👶 | | $+0.14$ | $+2$ | $0$ | $0$ | $0$ | | tables-adverse-events-aet05_all | 👶 | | $+0.13$ | $+2$ | $0$ | $0$ | $0$ | | tables-adverse-events-aet06 | 👶 | | $+1.88$ | $+5$ | $0$ | $0$ | $0$ | | tables-adverse-events-aet06_smq | 👶 | | $+0.37$ | $+3$ | $0$ | $0$ | $0$ | | tables-adverse-events-aet07 | 👶 | | $+0.12$ | $+2$ | $0$ | $0$ | $0$ | | tables-adverse-events-aet09 | 👶 | | $+0.33$ | $+2$ | $0$ | $0$ | $0$ | | tables-adverse-events-aet09_smq | 👶 | | $+0.17$ | $+2$ | $0$ | $0$ | $0$ | | tables-adverse-events-aet10 | 👶 | | $+0.21$ | $+2$ | $0$ | $0$ | $0$ | | tables-concomitant-medications-cmt01 | 👶 | | $+0.43$ | $+4$ | $0$ | $0$ | $0$ | | tables-concomitant-medications-cmt01a | 👶 | | $+0.72$ | $+4$ | $0$ | $0$ | $0$ | | tables-concomitant-medications-cmt01b | 👶 | | $+0.81$ | $+3$ | $0$ | $0$ | $0$ | | tables-concomitant-medications-cmt02_pt | 👶 | | $+0.09$ | $+1$ | $0$ | $0$ | $0$ | | tables-deaths-dtht01 | 👶 | | $+0.54$ | $+4$ | $0$ | $0$ | $0$ | | tables-demography-dmt01 | 👶 | | $+0.89$ | $+5$ | $0$ | $0$ | $0$ | | tables-disclosures-disclosurest01 | 👶 | | $+0.73$ | $+6$ | $0$ | $0$ | $0$ | | tables-disclosures-eudrat01 | 👶 | | $+0.15$ | $+1$ | $0$ | $0$ | $0$ | | tables-disclosures-eudrat02 | 👶 | | $+0.10$ | $+1$ | $0$ | $0$ | $0$ | | tables-disposition-dst01 | 👶 | | $+0.40$ | $+3$ | $0$ | $0$ | $0$ | | tables-disposition-pdt01 | 👶 | | $+0.17$ | $+1$ | $0$ | $0$ | $0$ | | tables-disposition-pdt02 | 👶 | | $+0.09$ | $+1$ | $0$ | $0$ | $0$ | | tables-efficacy-aovt01 | 👶 | | $+1.01$ | $+1$ | $0$ | $0$ | $0$ | | tables-efficacy-aovt02 | 👶 | | $+0.16$ | $+1$ | $0$ | $0$ | $0$ | | tables-efficacy-aovt03 | 👶 | | $+0.93$ | $+1$ | $0$ | $0$ | $0$ | | tables-efficacy-cfbt01 | 👶 | | $+0.25$ | $+1$ | $0$ | $0$ | $0$ | | tables-efficacy-cmht01 | 👶 | | $+2.33$ | $+2$ | $0$ | $0$ | $0$ | | tables-efficacy-coxt01 | 👶 | | $+0.49$ | $+4$ | $0$ | $0$ | $0$ | | tables-efficacy-coxt02 | 👶 | | $+0.17$ | $+2$ | $0$ | $0$ | $0$ | | tables-efficacy-dort01 | 👶 | | $+1.01$ | $+4$ | $0$ | $0$ | $0$ | | tables-efficacy-lgrt02 | 👶 | | $+0.91$ | $+4$ | $0$ | $0$ | $0$ | | tables-efficacy-mmrmt01 | 👶 | | $+0.64$ | $+4$ | $0$ | $0$ | $0$ | | tables-efficacy-onct05 | 👶 | | $+0.64$ | $+4$ | $0$ | $0$ | $0$ | | tables-efficacy-ratet01 | 👶 | | $+0.26$ | $+1$ | $0$ | $0$ | $0$ | | tables-efficacy-rspt01 | 👶 | | $+1.01$ | $+6$ | $0$ | $0$ | $0$ | | tables-efficacy-ttet01 | 👶 | | $+1.90$ | $+6$ | $0$ | $0$ | $0$ | | tables-exposure-ext01 | 👶 | | $+0.74$ | $+3$ | $0$ | $0$ | $0$ | | tables-lab-results-lbt01 | 👶 | | $+0.24$ | $+1$ | $0$ | $0$ | $0$ | | tables-lab-results-lbt02 | 👶 | | $+0.17$ | $+1$ | $0$ | $0$ | $0$ | | tables-lab-results-lbt03 | 👶 | | $+0.31$ | $+2$ | $0$ | $0$ | $0$ | | tables-lab-results-lbt04 | 👶 | | $+0.09$ | $+1$ | $0$ | $0$ | $0$ | | tables-lab-results-lbt05 | 👶 | | $+0.43$ | $+3$ | $0$ | $0$ | $0$ | | tables-lab-results-lbt06 | 👶 | | $+0.71$ | $+2$ | $0$ | $0$ | $0$ | | tables-lab-results-lbt07 | 👶 | | $+0.17$ | $+1$ | $0$ | $0$ | $0$ | | tables-lab-results-lbt08 | 👶 | | $+0.16$ | $+1$ | $0$ | $0$ | $0$ | | tables-lab-results-lbt09 | 👶 | | $+0.55$ | $+2$ | $0$ | $0$ | $0$ | | tables-lab-results-lbt10 | 👶 | | $+0.16$ | $+2$ | $0$ | $0$ | $0$ | | tables-lab-results-lbt10_bl | 👶 | | $+0.16$ | $+2$ | $0$ | $0$ | $0$ | | tables-lab-results-lbt11 | 👶 | | $+0.53$ | $+3$ | $0$ | $0$ | $0$ | | tables-lab-results-lbt11_bl | 👶 | | $+0.51$ | $+3$ | $0$ | $0$ | $0$ | | tables-lab-results-lbt12 | 👶 | | $+0.12$ | $+1$ | $0$ | $0$ | $0$ | | tables-lab-results-lbt12_bl | 👶 | | $+0.11$ | $+1$ | $0$ | $0$ | $0$ | | tables-lab-results-lbt13 | 👶 | | $+3.01$ | $+5$ | $0$ | $0$ | $0$ | | tables-lab-results-lbt14 | 👶 | | $+1.86$ | $+5$ | $0$ | $0$ | $0$ | | tables-lab-results-lbt15 | 👶 | | $+0.25$ | $+2$ | $0$ | $0$ | $0$ | | tables-medical-history-mht01 | 👶 | | $+0.54$ | $+4$ | $0$ | $0$ | $0$ | | tables-pharmacokinetic-pkct01 | 👶 | | $+0.89$ | $+3$ | $0$ | $0$ | $0$ | | tables-pharmacokinetic-pkpt02 | 👶 | | $+0.28$ | $+2$ | $0$ | $0$ | $0$ | | tables-pharmacokinetic-pkpt03 | 👶 | | $+1.45$ | $+3$ | $+3$ | $0$ | $0$ | | tables-pharmacokinetic-pkpt04 | 👶 | | $+0.34$ | $+2$ | $0$ | $0$ | $0$ | | tables-pharmacokinetic-pkpt05 | 👶 | | $+0.32$ | $+2$ | $0$ | $0$ | $0$ | | tables-pharmacokinetic-pkpt06 | 👶 | | $+0.16$ | $+2$ | $0$ | $0$ | $0$ | | tables-pharmacokinetic-pkpt07 | 👶 | | $+0.22$ | $+2$ | $0$ | $0$ | $0$ | | tables-pharmacokinetic-pkpt08 | 👶 | | $+0.15$ | $+1$ | $0$ | $0$ | $0$ | | tables-pharmacokinetic-pkpt11 | 👶 | | $+0.09$ | $+1$ | $0$ | $0$ | $0$ | | tables-risk-management-plan-rmpt01 | 👶 | | $+0.07$ | $+1$ | $0$ | $0$ | $0$ | | tables-risk-management-plan-rmpt03 | 👶 | | $+0.24$ | $+2$ | $0$ | $0$ | $0$ | | tables-risk-management-plan-rmpt04 | 👶 | | $+0.07$ | $+1$ | $0$ | $0$ | $0$ | | tables-risk-management-plan-rmpt05 | 👶 | | $+0.08$ | $+1$ | $0$ | $0$ | $0$ | | tables-risk-management-plan-rmpt06 | 👶 | | $+0.52$ | $+4$ | $0$ | $0$ | $0$ | | tables-safety-enrollment01 | 👶 | | $+2.32$ | $+4$ | $0$ | $0$ | $0$ | | tables-vital-signs-vst01 | 👶 | | $+0.35$ | $+1$ | $0$ | $0$ | $0$ | | tables-vital-signs-vst02 | 👶 | | $+0.39$ | $+2$ | $0$ | $0$ | $0$ |

Additional test case details

| Test Suite | $Status$ | Time on `main` | $±Time$ | Test Case | |:-----|:----:|:----:|:----:|:-----| | graph-snaps | 💀 | $0.17$ | $-0.17$ | _unnamed_ | | graph-snaps | 💀 | $3.25$ | $-3.25$ | plot_v1 | | graph-snaps | 💀 | $0.39$ | $-0.39$ | plot_v2 | | graph-snaps | 💀 | $0.09$ | $-0.09$ | plot_v3 | | graph-snaps | 💀 | $0.09$ | $-0.09$ | plot_v4 | | graph-snaps | 💀 | $0.07$ | $-0.07$ | plot_v5 | | graph-snaps | 💀 | $0.07$ | $-0.07$ | plot_v6 | | graph-snaps | 💀 | $0.03$ | $-0.03$ | plot_v7 | | graph-snaps | 💀 | $0.03$ | $-0.03$ | plot_v8 | | graph-snaps | 💀 | $0.03$ | $-0.03$ | plot_v9 | | graphs-efficacy-fstg01 | 👶 | | $+0.06$ | graphs_efficacy_fstg01.qmd_height_development | | graphs-efficacy-fstg01 | 👶 | | $+0.03$ | graphs_efficacy_fstg01.qmd_plot_v1_development | | graphs-efficacy-fstg01 | 👶 | | $+0.01$ | graphs_efficacy_fstg01.qmd_plot_v2_development | | graphs-efficacy-fstg01 | 👶 | | $+0.01$ | graphs_efficacy_fstg01.qmd_plot_v3_development | | graphs-efficacy-fstg01 | 👶 | | $+0.01$ | graphs_efficacy_fstg01.qmd_plot_v4_development | | graphs-efficacy-fstg01 | 👶 | | $+0.01$ | graphs_efficacy_fstg01.qmd_plot_v5_development | | graphs-efficacy-fstg01 | 👶 | | $+2.20$ | graphs_efficacy_fstg01.qmd_width_development | | graphs-efficacy-fstg02 | 👶 | | $+0.02$ | graphs_efficacy_fstg02.qmd_height_development | | graphs-efficacy-fstg02 | 👶 | | $+0.01$ | graphs_efficacy_fstg02.qmd_plot_v1_development | | graphs-efficacy-fstg02 | 👶 | | $+0.01$ | graphs_efficacy_fstg02.qmd_plot_v2_development | | graphs-efficacy-fstg02 | 👶 | | $+0.01$ | graphs_efficacy_fstg02.qmd_plot_v3.width_development | | graphs-efficacy-fstg02 | 👶 | | $+0.01$ | graphs_efficacy_fstg02.qmd_plot_v3_development | | graphs-efficacy-fstg02 | 👶 | | $+0.01$ | graphs_efficacy_fstg02.qmd_plot_v4_development | | graphs-efficacy-fstg02 | 👶 | | $+0.44$ | graphs_efficacy_fstg02.qmd_width_development | | graphs-efficacy-kmg01 | 👶 | | $+0.01$ | graphs_efficacy_kmg01.qmd_height_development | | graphs-efficacy-kmg01 | 👶 | | $+0.01$ | graphs_efficacy_kmg01.qmd_plot_v1_development | | graphs-efficacy-kmg01 | 👶 | | $+0.01$ | graphs_efficacy_kmg01.qmd_plot_v2_development | | graphs-efficacy-kmg01 | 👶 | | $+0.01$ | graphs_efficacy_kmg01.qmd_plot_v3_development | | graphs-efficacy-kmg01 | 👶 | | $+0.01$ | graphs_efficacy_kmg01.qmd_plot_v4_development | | graphs-efficacy-kmg01 | 👶 | | $+0.01$ | graphs_efficacy_kmg01.qmd_plot_v5_development | | graphs-efficacy-kmg01 | 👶 | | $+0.01$ | graphs_efficacy_kmg01.qmd_plot_v6_development | | graphs-efficacy-kmg01 | 👶 | | $+0.86$ | graphs_efficacy_kmg01.qmd_width_development | | graphs-efficacy-mmrmg01 | 👶 | | $+0.67$ | graphs_efficacy_mmrmg01.qmd_plot_v1_development | | graphs-efficacy-mmrmg01 | 👶 | | $+0.01$ | graphs_efficacy_mmrmg01.qmd_plot_v2_development | | graphs-efficacy-mmrmg01 | 👶 | | $+0.01$ | graphs_efficacy_mmrmg01.qmd_plot_v3_development | | graphs-efficacy-mmrmg01 | 👶 | | $+0.01$ | graphs_efficacy_mmrmg01.qmd_plot_v4_development | | graphs-efficacy-mmrmg01 | 👶 | | $+0.01$ | graphs_efficacy_mmrmg01.qmd_plot_v5_development | | graphs-efficacy-mmrmg01 | 👶 | | $+0.01$ | graphs_efficacy_mmrmg01.qmd_plot_v6_development | | graphs-efficacy-mmrmg02 | 👶 | | $+0.01$ | graphs_efficacy_mmrmg02.qmd_plot_v1_development | | graphs-efficacy-mmrmg02 | 👶 | | $+0.01$ | graphs_efficacy_mmrmg02.qmd_plot_v2_development | | graphs-efficacy-mmrmg02 | 👶 | | $+0.12$ | graphs_efficacy_mmrmg02.qmd_width_development | | graphs-other-brg01 | 👶 | | $+0.09$ | graphs_other_brg01.qmd_plot_v1_development | | graphs-other-brg01 | 👶 | | $+0.01$ | graphs_other_brg01.qmd_plot_v2_development | | graphs-other-brg01 | 👶 | | $+0.01$ | graphs_other_brg01.qmd_plot_v3_development | | graphs-other-brg01 | 👶 | | $+0.01$ | graphs_other_brg01.qmd_plot_v4_development | | graphs-other-brg01 | 👶 | | $+0.01$ | graphs_other_brg01.qmd_plot_v5_development | | graphs-other-brg01 | 👶 | | $+0.01$ | graphs_other_brg01.qmd_plot_v6_development | | graphs-other-brg01 | 👶 | | $+0.01$ | graphs_other_brg01.qmd_plot_v7_development | | graphs-other-brg01 | 👶 | | $+0.01$ | graphs_other_brg01.qmd_plot_v8_development | | graphs-other-brg01 | 👶 | | $+0.01$ | graphs_other_brg01.qmd_plot_v9_development | | graphs-other-bwg01 | 👶 | | $+0.56$ | graphs_other_bwg01.qmd_plot_v1_development | | graphs-other-bwg01 | 👶 | | $+0.01$ | graphs_other_bwg01.qmd_plot_v2_development | | graphs-other-bwg01 | 👶 | | $+0.01$ | graphs_other_bwg01.qmd_plot_v3_development | | graphs-other-bwg01 | 👶 | | $+0.01$ | graphs_other_bwg01.qmd_plot_v4_development | | graphs-other-bwg01 | 👶 | | $+0.01$ | graphs_other_bwg01.qmd_plot_v5_development | | graphs-other-bwg01 | 👶 | | $+0.01$ | graphs_other_bwg01.qmd_plot_v6_development | | graphs-other-bwg01 | 👶 | | $+0.01$ | graphs_other_bwg01.qmd_plot_v7_development | | graphs-other-bwg01 | 👶 | | $+0.01$ | graphs_other_bwg01.qmd_plot_v8_development | | graphs-other-bwg01 | 👶 | | $+0.01$ | graphs_other_bwg01.qmd_plot_v9_development | | graphs-other-cig01 | 👶 | | $+0.00$ | graphs_other_cig01.qmd_plot_v1_and_v2_development | | graphs-other-cig01 | 👶 | | $+0.01$ | graphs_other_cig01.qmd_plot_v3_development | | graphs-other-cig01 | 👶 | | $+0.01$ | graphs_other_cig01.qmd_plot_v4_development | | graphs-other-cig01 | 👶 | | $+0.01$ | graphs_other_cig01.qmd_plot_v5_development | | graphs-other-cig01 | 👶 | | $+0.18$ | graphs_other_cig01.qmd_table_v6_development | | graphs-other-ippg01 | 👶 | | $+0.05$ | graphs_other_ippg01.qmd_plots_v1_development | | graphs-other-ippg01 | 👶 | | $+0.01$ | graphs_other_ippg01.qmd_plots_v2_development | | graphs-other-ltg01 | 👶 | | $+0.09$ | graphs_other_ltg01.qmd_plot_v1_development | | graphs-other-ltg01 | 👶 | | $+0.01$ | graphs_other_ltg01.qmd_plot_v2_development | | graphs-other-ltg01 | 👶 | | $+0.01$ | graphs_other_ltg01.qmd_plot_v3_development | | graphs-other-ltg01 | 👶 | | $+0.01$ | graphs_other_ltg01.qmd_plot_v4_development | | graphs-other-ltg01 | 👶 | | $+0.01$ | graphs_other_ltg01.qmd_plot_v51_development | | graphs-other-ltg01 | 👶 | | $+0.01$ | graphs_other_ltg01.qmd_plot_v52_development | | graphs-other-ltg01 | 👶 | | $+0.01$ | graphs_other_ltg01.qmd_plot_v53_development | | graphs-other-mng01 | 👶 | | $+0.15$ | graphs_other_mng01.qmd_plot_v1_development | | graphs-other-mng01 | 👶 | | $+0.01$ | graphs_other_mng01.qmd_plot_v2_development | | graphs-other-mng01 | 👶 | | $+0.01$ | graphs_other_mng01.qmd_plot_v3_development | | graphs-other-mng01 | 👶 | | $+0.01$ | graphs_other_mng01.qmd_plot_v4_development | | graphs-other-mng01 | 👶 | | $+0.01$ | graphs_other_mng01.qmd_plot_v5_development | | graphs-other-mng01 | 👶 | | $+0.22$ | graphs_other_mng01.qmd_plot_v6_development | | graphs-other-mng01 | 👶 | | $+0.01$ | graphs_other_mng01.qmd_plot_v7_development | | graphs-pharmacokinetic-pkcg01 | 👶 | | $+0.04$ | graphs_pharmacokinetic_pkcg01.qmd_plot_v1_development | | graphs-pharmacokinetic-pkcg01 | 👶 | | $+0.01$ | graphs_pharmacokinetic_pkcg01.qmd_plot_v2_development | | graphs-pharmacokinetic-pkcg02 | 👶 | | $+0.03$ | graphs_pharmacokinetic_pkcg02.qmd_plot_v1_development | | graphs-pharmacokinetic-pkcg02 | 👶 | | $+0.01$ | graphs_pharmacokinetic_pkcg02.qmd_plot_v2_development | | graphs-pharmacokinetic-pkcg03 | 👶 | | $+0.05$ | graphs_pharmacokinetic_pkcg03.qmd_plot_v1_development | | graphs-pharmacokinetic-pkcg03 | 👶 | | $+0.01$ | graphs_pharmacokinetic_pkcg03.qmd_plot_v2_development | | graphs-pharmacokinetic-pkpg01 | 👶 | | $+0.05$ | graphs_pharmacokinetic_pkpg01.qmd_plot_v1_development | | graphs-pharmacokinetic-pkpg01 | 👶 | | $+0.01$ | graphs_pharmacokinetic_pkpg01.qmd_plot_v2_development | | graphs-pharmacokinetic-pkpg02 | 👶 | | $+0.06$ | graphs_pharmacokinetic_pkpg02.qmd_plot_v1_development | | graphs-pharmacokinetic-pkpg02 | 👶 | | $+0.01$ | graphs_pharmacokinetic_pkpg02.qmd_plot_v2_development | | graphs-pharmacokinetic-pkpg03 | 👶 | | $+0.04$ | graphs_pharmacokinetic_pkpg03.qmd_plot_v1_development | | graphs-pharmacokinetic-pkpg04 | 👶 | | $+0.05$ | graphs_pharmacokinetic_pkpg04.qmd_plot_v1_development | | graphs-pharmacokinetic-pkpg06 | 👶 | | $+0.03$ | graphs_pharmacokinetic_pkpg06.qmd_plot_v1_development | | graphs-pharmacokinetic-pkpg06 | 👶 | | $+0.01$ | graphs_pharmacokinetic_pkpg06.qmd_plot_v2_development | | graphs-pharmacokinetic-pkpg06 | 👶 | | $+0.01$ | graphs_pharmacokinetic_pkpg06.qmd_plot_v3_development | | graphs-pharmacokinetic-pkpg06 | 👶 | | $+0.01$ | graphs_pharmacokinetic_pkpg06.qmd_plot_v4_development | | listings-ADA-adal02 | 👶 | | $+0.06$ | listings_ADA_adal02.qmd_lsting_development | | listings-ECG-egl01 | 👶 | | $+0.05$ | listings_ECG_egl01.qmd_lsting_development | | listings-adverse-events-ael01 | 👶 | | $+0.04$ | listings_adverse_events_ael01.qmd_lsting_development | | listings-adverse-events-ael01_nollt | 👶 | | $+0.03$ | listings_adverse_events_ael01_nollt.qmd_lsting_development | | listings-adverse-events-ael02 | 👶 | | $+0.06$ | listings_adverse_events_ael02.qmd_lsting_development | | listings-adverse-events-ael02_ed | 👶 | | $+0.07$ | listings_adverse_events_ael02_ed.qmd_lsting_development | | listings-adverse-events-ael03 | 👶 | | $+0.05$ | listings_adverse_events_ael03.qmd_lsting_development | | listings-adverse-events-ael04 | 👶 | | $+0.04$ | listings_adverse_events_ael04.qmd_lsting_development | | listings-concomitant-medications-cml01 | 👶 | | $+0.06$ | listings_concomitant_medications_cml01.qmd_lsting_development | | listings-concomitant-medications-cml02a_gl | 👶 | | $+0.03$ | listings_concomitant_medications_cml02a_gl.qmd_lsting_development | | listings-concomitant-medications-cml02b_gl | 👶 | | $+0.04$ | listings_concomitant_medications_cml02b_gl.qmd_lsting_development | | listings-development-safety-update-report-dsur4 | 👶 | | $+0.04$ | listings_development_safety_update_report_dsur4.qmd_lsting_development | | listings-disposition-dsl01 | 👶 | | $+0.04$ | listings_disposition_dsl01.qmd_lsting_development | | listings-disposition-dsl02 | 👶 | | $+0.04$ | listings_disposition_dsl02.qmd_lsting_development | | listings-efficacy-oncl01 | 👶 | | $+0.05$ | listings_efficacy_oncl01.qmd_lsting_development | | listings-exposure-exl01 | 👶 | | $+0.05$ | listings_exposure_exl01.qmd_lsting_development | | listings-lab-results-lbl01 | 👶 | | $+0.05$ | listings_lab_results_lbl01.qmd_lsting_development | | listings-lab-results-lbl01_rls | 👶 | | $+0.05$ | listings_lab_results_lbl01_rls.qmd_lsting_development | | listings-lab-results-lbl02a | 👶 | | $+0.05$ | listings_lab_results_lbl02a.qmd_lsting_development | | listings-lab-results-lbl02a_rls | 👶 | | $+0.07$ | listings_lab_results_lbl02a_rls.qmd_lsting_development | | listings-lab-results-lbl02b | 👶 | | $+0.05$ | listings_lab_results_lbl02b.qmd_lsting_development | | listings-medical-history-mhl01 | 👶 | | $+0.05$ | listings_medical_history_mhl01.qmd_lsting_development | | listings-pharmacokinetic-pkcl01 | 👶 | | $+0.04$ | listings_pharmacokinetic_pkcl01.qmd_lsting_development | | listings-pharmacokinetic-pkcl02 | 👶 | | $+0.06$ | listings_pharmacokinetic_pkcl02.qmd_lsting_development | | listings-pharmacokinetic-pkpl01 | 👶 | | $+0.04$ | listings_pharmacokinetic_pkpl01.qmd_lsting_development | | listings-pharmacokinetic-pkpl02 | 👶 | | $+0.04$ | listings_pharmacokinetic_pkpl02.qmd_lsting_development | | listings-pharmacokinetic-pkpl04 | 👶 | | $+0.05$ | listings_pharmacokinetic_pkpl04.qmd_lsting_development | | listings-vital-signs-vsl01 | 👶 | | $+0.07$ | listings_vital_signs_vsl01.qmd_lsting_development | | markdown-snaps | 💀 | $1.32$ | $-1.32$ | lsting | | markdown-snaps | 💀 | $26.21$ | $-26.21$ | result_v1 | | markdown-snaps | 💀 | $0.17$ | $-0.17$ | result_v10 | | markdown-snaps | 💀 | $0.46$ | $-0.46$ | result_v11 | | markdown-snaps | 💀 | $0.10$ | $-0.10$ | result_v12 | | markdown-snaps | 💀 | $0.08$ | $-0.08$ | result_v13 | | markdown-snaps | 💀 | $8.83$ | $-8.83$ | result_v2 | | markdown-snaps | 💀 | $5.69$ | $-5.69$ | result_v3 | | markdown-snaps | 💀 | $4.58$ | $-4.58$ | result_v4 | | markdown-snaps | 💀 | $2.59$ | $-2.59$ | result_v5 | | markdown-snaps | 💀 | $0.92$ | $-0.92$ | result_v6 | | markdown-snaps | 💀 | $0.22$ | $-0.22$ | result_v7 | | markdown-snaps | 💀 | $0.69$ | $-0.69$ | result_v8 | | markdown-snaps | 💀 | $0.48$ | $-0.48$ | result_v9 | | tables-ADA-adat01 | 👶 | | $+0.21$ | tables_ADA_adat01.qmd_result_v1_development | | tables-ADA-adat02 | 👶 | | $+0.08$ | tables_ADA_adat02.qmd_result_v1_development | | tables-ADA-adat03 | 👶 | | $+0.33$ | tables_ADA_adat03.qmd_result_v1_development | | tables-ADA-adat04a | 👶 | | $+0.14$ | tables_ADA_adat04a.qmd_result_v1_development | | tables-ADA-adat04b | 👶 | | $+0.12$ | tables_ADA_adat04b.qmd_result_v1_development | | tables-ECG-egt01 | 👶 | | $+0.54$ | tables_ECG_egt01.qmd_result_v1_development | | tables-ECG-egt02 | 👶 | | $+0.09$ | tables_ECG_egt02.qmd_result_v1_development | | tables-ECG-egt02 | 👶 | | $+0.08$ | tables_ECG_egt02.qmd_result_v2_development | | tables-ECG-egt03 | 👶 | | $+1.22$ | tables_ECG_egt03.qmd_result_v1_development | | tables-ECG-egt03 | 👶 | | $+0.18$ | tables_ECG_egt03.qmd_result_v2_development | | tables-ECG-egt04 | 👶 | | $+0.17$ | tables_ECG_egt04.qmd_result_v1_development | | tables-ECG-egt05_qtcat | 👶 | | $+0.47$ | tables_ECG_egt05_qtcat.qmd_result_v1_development | | tables-adverse-events-aet01 | 👶 | | $+0.13$ | tables_adverse_events_aet01.qmd_result_v1_development | | tables-adverse-events-aet01 | 👶 | | $+0.12$ | tables_adverse_events_aet01.qmd_result_v2_development | | tables-adverse-events-aet01 | 👶 | | $+0.10$ | tables_adverse_events_aet01.qmd_result_v3_development | | tables-adverse-events-aet01 | 👶 | | $+0.12$ | tables_adverse_events_aet01.qmd_result_v4_development | | tables-adverse-events-aet01_aesi | 👶 | | $+0.13$ | tables_adverse_events_aet01_aesi.qmd_result_v1_development | | tables-adverse-events-aet01_aesi | 👶 | | $+0.15$ | tables_adverse_events_aet01_aesi.qmd_result_v2_development | | tables-adverse-events-aet01_aesi | 👶 | | $+0.21$ | tables_adverse_events_aet01_aesi.qmd_result_v3_development | | tables-adverse-events-aet01_aesi | 👶 | | $+0.15$ | tables_adverse_events_aet01_aesi.qmd_result_v4_development | | tables-adverse-events-aet02 | 👶 | | $+0.10$ | tables_adverse_events_aet02.qmd_result_v10_development | | tables-adverse-events-aet02 | 👶 | | $+0.09$ | tables_adverse_events_aet02.qmd_result_v11_development | | tables-adverse-events-aet02 | 👶 | | $+0.11$ | tables_adverse_events_aet02.qmd_result_v12_development | | tables-adverse-events-aet02 | 👶 | | $+0.08$ | tables_adverse_events_aet02.qmd_result_v13_development | | tables-adverse-events-aet02 | 👶 | | $+0.30$ | tables_adverse_events_aet02.qmd_result_v1_development | | tables-adverse-events-aet02 | 👶 | | $+0.19$ | tables_adverse_events_aet02.qmd_result_v2_development | | tables-adverse-events-aet02 | 👶 | | $+0.18$ | tables_adverse_events_aet02.qmd_result_v3_development | | tables-adverse-events-aet02 | 👶 | | $+0.25$ | tables_adverse_events_aet02.qmd_result_v4_development | | tables-adverse-events-aet02 | 👶 | | $+0.09$ | tables_adverse_events_aet02.qmd_result_v5_development | | tables-adverse-events-aet02 | 👶 | | $+0.16$ | tables_adverse_events_aet02.qmd_result_v6_development | | tables-adverse-events-aet02 | 👶 | | $+0.11$ | tables_adverse_events_aet02.qmd_result_v7_development | | tables-adverse-events-aet02 | 👶 | | $+0.13$ | tables_adverse_events_aet02.qmd_result_v8_development | | tables-adverse-events-aet02 | 👶 | | $+0.10$ | tables_adverse_events_aet02.qmd_result_v9_development | | tables-adverse-events-aet02_smq | 👶 | | $+0.08$ | tables_adverse_events_aet02_smq.qmd_result_v1_development | | tables-adverse-events-aet02_smq | 👶 | | $+0.09$ | tables_adverse_events_aet02_smq.qmd_result_v2_development | | tables-adverse-events-aet03 | 👶 | | $+0.33$ | tables_adverse_events_aet03.qmd_result_v1_development | | tables-adverse-events-aet04 | 👶 | | $+0.34$ | tables_adverse_events_aet04.qmd_result_v11_development | | tables-adverse-events-aet04 | 👶 | | $+0.58$ | tables_adverse_events_aet04.qmd_result_v1_development | | tables-adverse-events-aet04 | 👶 | | $+0.34$ | tables_adverse_events_aet04.qmd_result_v2_development | | tables-adverse-events-aet04 | 👶 | | $+0.63$ | tables_adverse_events_aet04.qmd_result_v3_development | | tables-adverse-events-aet04 | 👶 | | $+0.36$ | tables_adverse_events_aet04.qmd_result_v4_development | | tables-adverse-events-aet04 | 👶 | | $+0.34$ | tables_adverse_events_aet04.qmd_result_v6_development | | tables-adverse-events-aet04 | 👶 | | $+0.35$ | tables_adverse_events_aet04.qmd_result_v8_development | | tables-adverse-events-aet04 | 👶 | | $+0.43$ | tables_adverse_events_aet04.qmd_result_v9_development | | tables-adverse-events-aet04_pi | 👶 | | $+0.67$ | tables_adverse_events_aet04_pi.qmd_result_v1_development | | tables-adverse-events-aet04_pi | 👶 | | $+0.15$ | tables_adverse_events_aet04_pi.qmd_result_v2_development | | tables-adverse-events-aet04_pi | 👶 | | $+0.12$ | tables_adverse_events_aet04_pi.qmd_result_v3_development | | tables-adverse-events-aet04_pi | 👶 | | $+0.10$ | tables_adverse_events_aet04_pi.qmd_result_v4_development | | tables-adverse-events-aet04_pi | 👶 | | $+0.15$ | tables_adverse_events_aet04_pi.qmd_result_v5_development | | tables-adverse-events-aet04_pi | 👶 | | $+0.15$ | tables_adverse_events_aet04_pi.qmd_result_v6_development | | tables-adverse-events-aet04_pi | 👶 | | $+0.14$ | tables_adverse_events_aet04_pi.qmd_result_v7_development | | tables-adverse-events-aet04_pi | 👶 | | $+0.15$ | tables_adverse_events_aet04_pi.qmd_result_v8_development | | tables-adverse-events-aet05 | 👶 | | $+0.07$ | tables_adverse_events_aet05.qmd_result_v1_development | | tables-adverse-events-aet05 | 👶 | | $+0.07$ | tables_adverse_events_aet05.qmd_result_v2_development | | tables-adverse-events-aet05_all | 👶 | | $+0.07$ | tables_adverse_events_aet05_all.qmd_result_v1_development | | tables-adverse-events-aet05_all | 👶 | | $+0.06$ | tables_adverse_events_aet05_all.qmd_result_v2_development | | tables-adverse-events-aet06 | 👶 | | $+0.77$ | tables_adverse_events_aet06.qmd_result_v1_development | | tables-adverse-events-aet06 | 👶 | | $+0.26$ | tables_adverse_events_aet06.qmd_result_v2_development | | tables-adverse-events-aet06 | 👶 | | $+0.31$ | tables_adverse_events_aet06.qmd_result_v3_development | | tables-adverse-events-aet06 | 👶 | | $+0.22$ | tables_adverse_events_aet06.qmd_result_v4_development | | tables-adverse-events-aet06 | 👶 | | $+0.32$ | tables_adverse_events_aet06.qmd_result_v5_development | | tables-adverse-events-aet06_smq | 👶 | | $+0.14$ | tables_adverse_events_aet06_smq.qmd_result_v1_development | | tables-adverse-events-aet06_smq | 👶 | | $+0.13$ | tables_adverse_events_aet06_smq.qmd_result_v2_development | | tables-adverse-events-aet06_smq | 👶 | | $+0.10$ | tables_adverse_events_aet06_smq.qmd_result_v3_development | | tables-adverse-events-aet07 | 👶 | | $+0.06$ | tables_adverse_events_aet07.qmd_result_v1_development | | tables-adverse-events-aet07 | 👶 | | $+0.06$ | tables_adverse_events_aet07.qmd_result_v2_development | | tables-adverse-events-aet09 | 👶 | | $+0.16$ | tables_adverse_events_aet09.qmd_result_v1_development | | tables-adverse-events-aet09 | 👶 | | $+0.17$ | tables_adverse_events_aet09.qmd_result_v2_development | | tables-adverse-events-aet09_smq | 👶 | | $+0.08$ | tables_adverse_events_aet09_smq.qmd_result_v1_development | | tables-adverse-events-aet09_smq | 👶 | | $+0.09$ | tables_adverse_events_aet09_smq.qmd_result_v2_development | | tables-adverse-events-aet10 | 👶 | | $+0.12$ | tables_adverse_events_aet10.qmd_result_v1_development | | tables-adverse-events-aet10 | 👶 | | $+0.09$ | tables_adverse_events_aet10.qmd_result_v2_development | | tables-concomitant-medications-cmt01 | 👶 | | $+0.13$ | tables_concomitant_medications_cmt01.qmd_result_v1_development | | tables-concomitant-medications-cmt01 | 👶 | | $+0.09$ | tables_concomitant_medications_cmt01.qmd_result_v2_development | | tables-concomitant-medications-cmt01 | 👶 | | $+0.10$ | tables_concomitant_medications_cmt01.qmd_result_v3_development | | tables-concomitant-medications-cmt01 | 👶 | | $+0.12$ | tables_concomitant_medications_cmt01.qmd_result_v4_development | | tables-concomitant-medications-cmt01a | 👶 | | $+0.23$ | tables_concomitant_medications_cmt01a.qmd_result_v1_development | | tables-concomitant-medications-cmt01a | 👶 | | $+0.17$ | tables_concomitant_medications_cmt01a.qmd_result_v2_development | | tables-concomitant-medications-cmt01a | 👶 | | $+0.17$ | tables_concomitant_medications_cmt01a.qmd_result_v3_development | | tables-concomitant-medications-cmt01a | 👶 | | $+0.15$ | tables_concomitant_medications_cmt01a.qmd_result_v4_development | | tables-concomitant-medications-cmt01b | 👶 | | $+0.33$ | tables_concomitant_medications_cmt01b.qmd_result_v1_development | | tables-concomitant-medications-cmt01b | 👶 | | $+0.20$ | tables_concomitant_medications_cmt01b.qmd_result_v2_development | | tables-concomitant-medications-cmt01b | 👶 | | $+0.28$ | tables_concomitant_medications_cmt01b.qmd_result_v4_development | | tables-concomitant-medications-cmt02_pt | 👶 | | $+0.09$ | tables_concomitant_medications_cmt02_pt.qmd_result_v1_development | | tables-deaths-dtht01 | 👶 | | $+0.19$ | tables_deaths_dtht01.qmd_result_v1_development | | tables-deaths-dtht01 | 👶 | | $+0.14$ | tables_deaths_dtht01.qmd_result_v2_development | | tables-deaths-dtht01 | 👶 | | $+0.09$ | tables_deaths_dtht01.qmd_result_v3_development | | tables-deaths-dtht01 | 👶 | | $+0.10$ | tables_deaths_dtht01.qmd_result_v4_development | | tables-demography-dmt01 | 👶 | | $+0.22$ | tables_demography_dmt01.qmd_result_v1_development | | tables-demography-dmt01 | 👶 | | $+0.17$ | tables_demography_dmt01.qmd_result_v2_development | | tables-demography-dmt01 | 👶 | | $+0.23$ | tables_demography_dmt01.qmd_result_v3_development | | tables-demography-dmt01 | 👶 | | $+0.14$ | tables_demography_dmt01.qmd_result_v4_development | | tables-demography-dmt01 | 👶 | | $+0.14$ | tables_demography_dmt01.qmd_result_v5_development | | tables-disclosures-disclosurest01 | 👶 | | $+0.16$ | tables_disclosures_disclosurest01.qmd_result_v1_development | | tables-disclosures-disclosurest01 | 👶 | | $+0.18$ | tables_disclosures_disclosurest01.qmd_result_v2_development | | tables-disclosures-disclosurest01 | 👶 | | $+0.10$ | tables_disclosures_disclosurest01.qmd_result_v3_development | | tables-disclosures-disclosurest01 | 👶 | | $+0.12$ | tables_disclosures_disclosurest01.qmd_result_v4_development | | tables-disclosures-disclosurest01 | 👶 | | $+0.11$ | tables_disclosures_disclosurest01.qmd_result_v5_development | | tables-disclosures-disclosurest01 | 👶 | | $+0.06$ | tables_disclosures_disclosurest01.qmd_result_v6_development | | tables-disclosures-eudrat01 | 👶 | | $+0.15$ | tables_disclosures_eudrat01.qmd_result_v1_development | | tables-disclosures-eudrat02 | 👶 | | $+0.10$ | tables_disclosures_eudrat02.qmd_result_v1_development | | tables-disposition-dst01 | 👶 | | $+0.19$ | tables_disposition_dst01.qmd_result_v1_development | | tables-disposition-dst01 | 👶 | | $+0.10$ | tables_disposition_dst01.qmd_result_v2_development | | tables-disposition-dst01 | 👶 | | $+0.11$ | tables_disposition_dst01.qmd_result_v3_development | | tables-disposition-pdt01 | 👶 | | $+0.17$ | tables_disposition_pdt01.qmd_result_v1_development | | tables-disposition-pdt02 | 👶 | | $+0.09$ | tables_disposition_pdt02.qmd_result_v1_development | | tables-efficacy-aovt01 | 👶 | | $+1.01$ | tables_efficacy_aovt01.qmd_result_v1_development | | tables-efficacy-aovt02 | 👶 | | $+0.16$ | tables_efficacy_aovt02.qmd_result_v1_development | | tables-efficacy-aovt03 | 👶 | | $+0.93$ | tables_efficacy_aovt03.qmd_result_v1_development | | tables-efficacy-cfbt01 | 👶 | | $+0.25$ | tables_efficacy_cfbt01.qmd_result_v1_development | | tables-efficacy-cmht01 | 👶 | | $+2.07$ | tables_efficacy_cmht01.qmd_result_v1_development | | tables-efficacy-cmht01 | 👶 | | $+0.26$ | tables_efficacy_cmht01.qmd_result_v2_development | | tables-efficacy-coxt01 | 👶 | | $+0.17$ | tables_efficacy_coxt01.qmd_result_v1_development | | tables-efficacy-coxt01 | 👶 | | $+0.12$ | tables_efficacy_coxt01.qmd_result_v2_development | | tables-efficacy-coxt01 | 👶 | | $+0.10$ | tables_efficacy_coxt01.qmd_result_v3_development | | tables-efficacy-coxt01 | 👶 | | $+0.10$ | tables_efficacy_coxt01.qmd_result_v4_development | | tables-efficacy-coxt02 | 👶 | | $+0.10$ | tables_efficacy_coxt02.qmd_result_v1_development | | tables-efficacy-coxt02 | 👶 | | $+0.07$ | tables_efficacy_coxt02.qmd_result_v2_development | | tables-efficacy-dort01 | 👶 | | $+0.70$ | tables_efficacy_dort01.qmd_result_v1_development | | tables-efficacy-dort01 | 👶 | | $+0.10$ | tables_efficacy_dort01.qmd_result_v2_development | | tables-efficacy-dort01 | 👶 | | $+0.10$ | tables_efficacy_dort01.qmd_result_v3_development | | tables-efficacy-dort01 | 👶 | | $+0.10$ | tables_efficacy_dort01.qmd_result_v4_development | | tables-efficacy-lgrt02 | 👶 | | $+0.45$ | tables_efficacy_lgrt02.qmd_result_v1_development | | tables-efficacy-lgrt02 | 👶 | | $+0.16$ | tables_efficacy_lgrt02.qmd_result_v2_development | | tables-efficacy-lgrt02 | 👶 | | $+0.14$ | tables_efficacy_lgrt02.qmd_result_v3_development | | tables-efficacy-lgrt02 | 👶 | | $+0.17$ | tables_efficacy_lgrt02.qmd_result_v4_development | | tables-efficacy-mmrmt01 | 👶 | | $+0.09$ | tables_efficacy_mmrmt01.qmd_result_baseline_development | | tables-efficacy-mmrmt01 | 👶 | | $+0.21$ | tables_efficacy_mmrmt01.qmd_result_v1_development | | tables-efficacy-mmrmt01 | 👶 | | $+0.09$ | tables_efficacy_mmrmt01.qmd_result_v2_development | | tables-efficacy-mmrmt01 | 👶 | | $+0.25$ | tables_efficacy_mmrmt01.qmd_result_v3_development | | tables-efficacy-onct05 | 👶 | | $+0.24$ | tables_efficacy_onct05.qmd_result_v1_development | | tables-efficacy-onct05 | 👶 | | $+0.13$ | tables_efficacy_onct05.qmd_result_v2_development | | tables-efficacy-onct05 | 👶 | | $+0.15$ | tables_efficacy_onct05.qmd_result_v3_development | | tables-efficacy-onct05 | 👶 | | $+0.12$ | tables_efficacy_onct05.qmd_result_v4_development | | tables-efficacy-ratet01 | 👶 | | $+0.26$ | tables_efficacy_ratet01.qmd_result_v1_development | | tables-efficacy-rspt01 | 👶 | | $+0.46$ | tables_efficacy_rspt01.qmd_result_v1_development | | tables-efficacy-rspt01 | 👶 | | $+0.11$ | tables_efficacy_rspt01.qmd_result_v2_development | | tables-efficacy-rspt01 | 👶 | | $+0.11$ | tables_efficacy_rspt01.qmd_result_v3_development | | tables-efficacy-rspt01 | 👶 | | $+0.13$ | tables_efficacy_rspt01.qmd_result_v4_development | | tables-efficacy-rspt01 | 👶 | | $+0.11$ | tables_efficacy_rspt01.qmd_result_v5_development | | tables-efficacy-rspt01 | 👶 | | $+0.10$ | tables_efficacy_rspt01.qmd_result_v6_development | | tables-efficacy-ttet01 | 👶 | | $+1.21$ | tables_efficacy_ttet01.qmd_result_v1_development | | tables-efficacy-ttet01 | 👶 | | $+0.13$ | tables_efficacy_ttet01.qmd_result_v2_development | | tables-efficacy-ttet01 | 👶 | | $+0.14$ | tables_efficacy_ttet01.qmd_result_v3_development | | tables-efficacy-ttet01 | 👶 | | $+0.15$ | tables_efficacy_ttet01.qmd_result_v4_development | | tables-efficacy-ttet01 | 👶 | | $+0.14$ | tables_efficacy_ttet01.qmd_result_v5_development | | tables-efficacy-ttet01 | 👶 | | $+0.14$ | tables_efficacy_ttet01.qmd_result_v6_development | | tables-exposure-ext01 | 👶 | | $+0.32$ | tables_exposure_ext01.qmd_result_v1_development | | tables-exposure-ext01 | 👶 | | $+0.19$ | tables_exposure_ext01.qmd_result_v2_development | | tables-exposure-ext01 | 👶 | | $+0.23$ | tables_exposure_ext01.qmd_result_v3_development | | tables-lab-results-lbt01 | 👶 | | $+0.24$ | tables_lab_results_lbt01.qmd_result_v1_development | | tables-lab-results-lbt02 | 👶 | | $+0.17$ | tables_lab_results_lbt02.qmd_result_v1_development | | tables-lab-results-lbt03 | 👶 | | $+0.17$ | tables_lab_results_lbt03.qmd_result_v1_development | | tables-lab-results-lbt03 | 👶 | | $+0.14$ | tables_lab_results_lbt03.qmd_result_v2_development | | tables-lab-results-lbt04 | 👶 | | $+0.09$ | tables_lab_results_lbt04.qmd_result_v1_development | | tables-lab-results-lbt05 | 👶 | | $+0.16$ | tables_lab_results_lbt05.qmd_result_v1_development | | tables-lab-results-lbt05 | 👶 | | $+0.15$ | tables_lab_results_lbt05.qmd_result_v2_development | | tables-lab-results-lbt05 | 👶 | | $+0.12$ | tables_lab_results_lbt05.qmd_result_v4_development | | tables-lab-results-lbt06 | 👶 | | $+0.24$ | tables_lab_results_lbt06.qmd_result_v1_development | | tables-lab-results-lbt06 | 👶 | | $+0.47$ | tables_lab_results_lbt06.qmd_result_v2_development | | tables-lab-results-lbt07 | 👶 | | $+0.17$ | tables_lab_results_lbt07.qmd_result_v1_development | | tables-lab-results-lbt08 | 👶 | | $+0.16$ | tables_lab_results_lbt08.qmd_result_v1_development | | tables-lab-results-lbt09 | 👶 | | $+0.35$ | tables_lab_results_lbt09.qmd_result_v1_development | | tables-lab-results-lbt09 | 👶 | | $+0.20$ | tables_lab_results_lbt09.qmd_result_v2_development | | tables-lab-results-lbt10 | 👶 | | $+0.09$ | tables_lab_results_lbt10.qmd_result_v1_development | | tables-lab-results-lbt10 | 👶 | | $+0.07$ | tables_lab_results_lbt10.qmd_result_v2_development | | tables-lab-results-lbt10_bl | 👶 | | $+0.09$ | tables_lab_results_lbt10_bl.qmd_result_v1_development | | tables-lab-results-lbt10_bl | 👶 | | $+0.07$ | tables_lab_results_lbt10_bl.qmd_result_v2_development | | tables-lab-results-lbt11 | 👶 | | $+0.32$ | tables_lab_results_lbt11.qmd_result_v1_development | | tables-lab-results-lbt11 | 👶 | | $+0.08$ | tables_lab_results_lbt11.qmd_result_v2_development | | tables-lab-results-lbt11 | 👶 | | $+0.13$ | tables_lab_results_lbt11.qmd_result_v3_development | | tables-lab-results-lbt11_bl | 👶 | | $+0.32$ | tables_lab_results_lbt11_bl.qmd_result_v1_development | | tables-lab-results-lbt11_bl | 👶 | | $+0.08$ | tables_lab_results_lbt11_bl.qmd_result_v2_development | | tables-lab-results-lbt11_bl | 👶 | | $+0.11$ | tables_lab_results_lbt11_bl.qmd_result_v3_development | | tables-lab-results-lbt12 | 👶 | | $+0.12$ | tables_lab_results_lbt12.qmd_result_v1_development | | tables-lab-results-lbt12_bl | 👶 | | $+0.11$ | tables_lab_results_lbt12_bl.qmd_result_v1_development | | tables-lab-results-lbt13 | 👶 | | $+0.73$ | tables_lab_results_lbt13.qmd_result_v1_development | | tables-lab-results-lbt13 | 👶 | | $+0.48$ | tables_lab_results_lbt13.qmd_result_v2_development | | tables-lab-results-lbt13 | 👶 | | $+0.46$ | tables_lab_results_lbt13.qmd_result_v3_development | | tables-lab-results-lbt13 | 👶 | | $+0.48$ | tables_lab_results_lbt13.qmd_result_v4_development | | tables-lab-results-lbt13 | 👶 | | $+0.86$ | tables_lab_results_lbt13.qmd_result_v5_development | | tables-lab-results-lbt14 | 👶 | | $+0.48$ | tables_lab_results_lbt14.qmd_result_v1_development | | tables-lab-results-lbt14 | 👶 | | $+0.28$ | tables_lab_results_lbt14.qmd_result_v2_development | | tables-lab-results-lbt14 | 👶 | | $+0.28$ | tables_lab_results_lbt14.qmd_result_v3_development | | tables-lab-results-lbt14 | 👶 | | $+0.28$ | tables_lab_results_lbt14.qmd_result_v4_development | | tables-lab-results-lbt14 | 👶 | | $+0.55$ | tables_lab_results_lbt14.qmd_result_v5_development | | tables-lab-results-lbt15 | 👶 | | $+0.14$ | tables_lab_results_lbt15.qmd_result_v1_development | | tables-lab-results-lbt15 | 👶 | | $+0.11$ | tables_lab_results_lbt15.qmd_result_v2_development | | tables-medical-history-mht01 | 👶 | | $+0.17$ | tables_medical_history_mht01.qmd_result_v1_development | | tables-medical-history-mht01 | 👶 | | $+0.07$ | tables_medical_history_mht01.qmd_result_v2_development | | tables-medical-history-mht01 | 👶 | | $+0.14$ | tables_medical_history_mht01.qmd_result_v3_development | | tables-medical-history-mht01 | 👶 | | $+0.17$ | tables_medical_history_mht01.qmd_result_v4_development | | tables-pharmacokinetic-pkct01 | 👶 | | $+0.50$ | tables_pharmacokinetic_pkct01.qmd_result_v1_development | | tables-pharmacokinetic-pkct01 | 👶 | | $+0.20$ | tables_pharmacokinetic_pkct01.qmd_result_v2_development | | tables-pharmacokinetic-pkct01 | 👶 | | $+0.19$ | tables_pharmacokinetic_pkct01.qmd_result_v3_development | | tables-pharmacokinetic-pkpt02 | 👶 | | $+0.17$ | tables_pharmacokinetic_pkpt02.qmd_result_v1_development | | tables-pharmacokinetic-pkpt02 | 👶 | | $+0.11$ | tables_pharmacokinetic_pkpt02.qmd_result_v2_development | | tables-pharmacokinetic-pkpt03 | 👶 | | $+1.42$ | tables_pharmacokinetic_pkpt03.qmd_result_v1_development | | tables-pharmacokinetic-pkpt03 | 👶 | | $+0.01$ | tables_pharmacokinetic_pkpt03.qmd_result_v2_development | | tables-pharmacokinetic-pkpt03 | 👶 | | $+0.01$ | tables_pharmacokinetic_pkpt03.qmd_result_v3_development | | tables-pharmacokinetic-pkpt04 | 👶 | | $+0.20$ | tables_pharmacokinetic_pkpt04.qmd_result_v1_development | | tables-pharmacokinetic-pkpt04 | 👶 | | $+0.13$ | tables_pharmacokinetic_pkpt04.qmd_result_v2_development | | tables-pharmacokinetic-pkpt05 | 👶 | | $+0.19$ | tables_pharmacokinetic_pkpt05.qmd_result_v1_development | | tables-pharmacokinetic-pkpt05 | 👶 | | $+0.13$ | tables_pharmacokinetic_pkpt05.qmd_result_v2_development | | tables-pharmacokinetic-pkpt06 | 👶 | | $+0.09$ | tables_pharmacokinetic_pkpt06.qmd_result_v1_development | | tables-pharmacokinetic-pkpt06 | 👶 | | $+0.07$ | tables_pharmacokinetic_pkpt06.qmd_result_v2_development | | tables-pharmacokinetic-pkpt07 | 👶 | | $+0.12$ | tables_pharmacokinetic_pkpt07.qmd_result_v1_development | | tables-pharmacokinetic-pkpt07 | 👶 | | $+0.10$ | tables_pharmacokinetic_pkpt07.qmd_result_v2_development | | tables-pharmacokinetic-pkpt08 | 👶 | | $+0.15$ | tables_pharmacokinetic_pkpt08.qmd_result_v1_development | | tables-pharmacokinetic-pkpt11 | 👶 | | $+0.09$ | tables_pharmacokinetic_pkpt11.qmd_result_v1_development | | tables-risk-management-plan-rmpt01 | 👶 | | $+0.07$ | tables_risk_management_plan_rmpt01.qmd_result_v1_development | | tables-risk-management-plan-rmpt03 | 👶 | | $+0.14$ | tables_risk_management_plan_rmpt03.qmd_result_v1_development | | tables-risk-management-plan-rmpt03 | 👶 | | $+0.10$ | tables_risk_management_plan_rmpt03.qmd_result_v2_development | | tables-risk-management-plan-rmpt04 | 👶 | | $+0.07$ | tables_risk_management_plan_rmpt04.qmd_result_v1_development | | tables-risk-management-plan-rmpt05 | 👶 | | $+0.08$ | tables_risk_management_plan_rmpt05.qmd_result_v1_development | | tables-risk-management-plan-rmpt06 | 👶 | | $+0.18$ | tables_risk_management_plan_rmpt06.qmd_result_v1_development | | tables-risk-management-plan-rmpt06 | 👶 | | $+0.10$ | tables_risk_management_plan_rmpt06.qmd_result_v2_development | | tables-risk-management-plan-rmpt06 | 👶 | | $+0.13$ | tables_risk_management_plan_rmpt06.qmd_result_v3_development | | tables-risk-management-plan-rmpt06 | 👶 | | $+0.12$ | tables_risk_management_plan_rmpt06.qmd_result_v4_development | | tables-safety-enrollment01 | 👶 | | $+0.76$ | tables_safety_enrollment01.qmd_result_v1_development | | tables-safety-enrollment01 | 👶 | | $+0.50$ | tables_safety_enrollment01.qmd_result_v2_development | | tables-safety-enrollment01 | 👶 | | $+0.55$ | tables_safety_enrollment01.qmd_result_v3_development | | tables-safety-enrollment01 | 👶 | | $+0.50$ | tables_safety_enrollment01.qmd_result_v4_development | | tables-vital-signs-vst01 | 👶 | | $+0.35$ | tables_vital_signs_vst01.qmd_result_v1_development | | tables-vital-signs-vst02 | 👶 | | $+0.26$ | tables_vital_signs_vst02.qmd_result_v1_development | | tables-vital-signs-vst02 | 👶 | | $+0.12$ | tables_vital_signs_vst02.qmd_result_v2_development |

Results for commit b4daf09c5dbb35503ff3410c9683764faf721e97

♻️ This comment has been updated with latest results.